GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrthoPediatrics Corp (NAS:KIDS) » Definitions » Net Current Asset Value

KIDS (OrthoPediatrics) Net Current Asset Value : $4.39 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is OrthoPediatrics Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

OrthoPediatrics's net current asset value per share for the quarter that ended in Mar. 2025 was $4.39.

The historical rank and industry rank for OrthoPediatrics's Net Current Asset Value or its related term are showing as below:

KIDS' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 4.44   Med: 8.63   Max: 24.35
Current: 4.62

During the past 11 years, the highest Price-to-Net-Current-Asset-Value Ratio of OrthoPediatrics was 24.35. The lowest was 4.44. And the median was 8.63.

KIDS's Price-to-Net-Current-Asset-Value is ranked better than
53.09% of 582 companies
in the Medical Devices & Instruments industry
Industry Median: 4.94 vs KIDS: 4.62

OrthoPediatrics Net Current Asset Value Historical Data

The historical data trend for OrthoPediatrics's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrthoPediatrics Net Current Asset Value Chart

OrthoPediatrics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.72 2.78 7.76 7.05 4.89

OrthoPediatrics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.83 5.55 5.37 4.89 4.39

Competitive Comparison of OrthoPediatrics's Net Current Asset Value

For the Medical Devices subindustry, OrthoPediatrics's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrthoPediatrics's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrthoPediatrics's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where OrthoPediatrics's Price-to-Net-Current-Asset-Value falls into.


;
;

OrthoPediatrics Net Current Asset Value Calculation

OrthoPediatrics's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2024 is calculated as

Net Current Asset Value Per Share(A: Dec. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(237.173-118.643-0-0)/24.218
=4.89

OrthoPediatrics's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2025 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2025 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(232.059-123.104-0-0)/24.828
=4.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrthoPediatrics  (NAS:KIDS) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


OrthoPediatrics Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of OrthoPediatrics's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


OrthoPediatrics Business Description

Traded in Other Exchanges
Address
2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Executives
Joseph W Hauser officer: Sr VP & GM Trauma & Deformity 6428 RIDGELINE DR, HUDSON OH 44236
Fred Hite director, officer: Chief Financial Officer ORTHOPEDIATRICS, 2850 FRONTIER DR., WARSAW IN 46582
Daniel J Gerritzen officer: General Counsel and Secretary 2850 FRONTIER DRIVE, WARSAW IN 46582
David R Bailey officer: Executive Vice President 2850 FRONTIER DRIVE, WARSAW IN 46582
Gregory A Odle officer: Executive Vice President 2850 FRONTIER DRIVE, WARSAW IN 46582
Mark C Throdahl director, officer: President and CEO ORTHOPEDIATRICS, 2850 FRONTER DR., WARSAW IN 46582
Terry D Schlotterback director 2850 FRONTIER DRIVE, WARSAW IN 46582
Dyer George Sinclair Mitchell director 55 ORCHARD ST., CAMBRIDGE MA 02140
Jimmy Duane Mcdonald director 28662 N. 71ST STREET, SCOTTSDALE AZ 85226
David R Pelizzon director, 10 percent owner 2850 FRONTIER DR, WARSAW IN 46582
Squadron Capital Holdings Llc 10 percent owner 18 HARTFORD AVENUE, PO BOX 223, GRANBY CT 06053
Squadron Capital Llc 10 percent owner 2850 FRONTIER DR., WARSAW IN 46582
Harold Ruf director 2850 FRONTIER DR, WARSAW IN 46582
Jennifer N. Pritzker 10 percent owner C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Infante (reynolds) Marie C director 2850 FRONTIER DR, WARSAW IN 46582